SARS coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, emerged in China in
December 2019. Vaccines developed were very effective initially, however, the virus has …

SARS-CoV-2 can cause lung diseases, such as pneumonia and acute respiratory distress
syndrome, and multi-system dysfunction. Post-translational modifications (PTMs) related to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …

The S-protein is the major antigen of the SARS-CoV-2 virus, against which protective
antibodies are generated. The S-protein gene was used in adenoviral vectors and mRNA …

COVID-19 is caused by SARS-CoV-2 infection and remains one of the biggest pandemics
around the world since 2019. Vaccination has proved to be an effective way of preventing …

Viral tropism is most commonly linked to receptor use, but host cell protease use can be a
notable factor in susceptibility to infection. Here we review the use of host cell proteases by …

Voltage-gated sodium channel α-subunits (NaV1. 1–1.9) initiate and propagate action
potentials in neurons and myocytes. The NaV β-subunits (β1–4) have been shown to …

SARS-CoV-2 Omicron subvariants with increased transmissibility and immune evasion are
spreading globally with alarming persistence. Whether the mutations and evolution of spike …

It has been postulated from a combination of evidence that a sudden increase in COVID-19
cases among pediatric patients after onset of the Omicron wave was attributed to a reduced …

Following COVID-19 outbreak with its unprecedented effect on the entire world, the interest
to the coronaviruses increased. The causative agent of the COVID-19, severe acute …